E Sun Paik, M.D., Ph.D., is an Associate Professor in the Department of Obstetrics and Gynecology at Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Republic of Korea. He received his M.D. from Korea University College of Medicine, followed by his MSc. and Ph.D. in Obstetrics and Gynecology from Sungkyunkwan University. Prior to his current role, he completed his residency and clinical fellowship in Gynecologic Oncology at Samsung Medical Center. His clinical and translational research primarily focuses on gynecologic oncology, particularly epithelial ovarian cancer, prognostic biomarkers, and minimally invasive surgery. Dr. Paik has published extensively on perioperative inflammatory indices, machine learning models for survival prediction, and personalized targeted therapies involving BRCA mutations and PARP inhibitors. He is actively engaged in professional societies, currently serving as Secretary of the Ovarian Cancer Committee for the Korean Gynecologic Oncology Group (KGOG). He is also a regular member of the Korean Society of Gynecologic Oncology (KSGO) and the Korean Society of Obstetrics and Gynecology (KSOG), where he has held numerous prominent committee roles over the years. His notable academic contributions have been recognized with multiple honors, including the Best Paper Award from the Journal of Gynecologic Oncology (2021), the Academic Award in Gynecologic Oncology from KSOG (2020), and the Young Investigator Award from KSGO (2017)
E Sun Paik, M.D., Ph.D., is an Associate Professor in the Department of Obstetrics and Gynecology at Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Republic of Korea. He received his M.D. from Korea University College of Medicine, followed by his MSc. and Ph.D. in Obstetrics and Gynecology from Sungkyunkwan University. Prior to his current role, he completed his residency and clinical fellowship in Gynecologic Oncology at Samsung Medical Center. His clinical and translational research primarily focuses on gynecologic oncology, particularly epithelial ovarian cancer, prognostic biomarkers, and minimally invasive surgery. Dr. Paik has published extensively on perioperative inflammatory indices, machine learning models for survival prediction, and personalized targeted therapies involving BRCA mutations and PARP inhibitors. He is actively engaged in professional societies, currently serving as Secretary of the Ovarian Cancer Committee for the Korean Gynecologic Oncology Group (KGOG). He is also a regular member of the Korean Society of Gynecologic Oncology (KSGO) and the Korean Society of Obstetrics and Gynecology (KSOG), where he has held numerous prominent committee roles over the years. His notable academic contributions have been recognized with multiple honors, including the Best Paper Award from the Journal of Gynecologic Oncology (2021), the Academic Award in Gynecologic Oncology from KSOG (2020), and the Young Investigator Award from KSGO (2017)